ACTIVE SUBSTANCE COMBINATION

The present invention relates to an active substance combination comprising at least one substituted pyrazoline compound and at least one anti-addictive compound, a medicament comprising said active substance combination, a pharmaceutical formulation comprising said active substance combination and...

Full description

Saved in:
Bibliographic Details
Main Author BUSCHMANN, HELMUT, H
Format Patent
LanguageEnglish
French
Published 25.01.2007
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to an active substance combination comprising at least one substituted pyrazoline compound and at least one anti-addictive compound, a medicament comprising said active substance combination, a pharmaceutical formulation comprising said active substance combination and the use of said active substance combination for the manufacture of a medicament. L'invention concerne une combinaison de substances actives comprenant au moins un composé de pyrazoline substitué et au moins un composé anti-toxicomanogène, un médicament comprenant la combinaison de substances actives, une formulation pharmaceutique comprenant la combinaison de substances actives et l'utilisation de la combinaison de substances actives dans la fabrication d'un médicament.
AbstractList The present invention relates to an active substance combination comprising at least one substituted pyrazoline compound and at least one anti-addictive compound, a medicament comprising said active substance combination, a pharmaceutical formulation comprising said active substance combination and the use of said active substance combination for the manufacture of a medicament. L'invention concerne une combinaison de substances actives comprenant au moins un composé de pyrazoline substitué et au moins un composé anti-toxicomanogène, un médicament comprenant la combinaison de substances actives, une formulation pharmaceutique comprenant la combinaison de substances actives et l'utilisation de la combinaison de substances actives dans la fabrication d'un médicament.
Author BUSCHMANN, HELMUT, H
Author_xml – fullname: BUSCHMANN, HELMUT, H
BookMark eNrjYmDJy89L5WSQcXQO8QxzVQgOdQoOcfRzdlVw9vd18vRzDPH09-NhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGBuYGBpZmloaORsbEqQIA1zkjjg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate COMBINAISON DE SUBSTANCES ACTIVE S
ExternalDocumentID WO2007009691A2
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2007009691A23
IEDL.DBID EVB
IngestDate Fri Jul 19 12:48:29 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2007009691A23
Notes Application Number: WO2006EP06965
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070125&DB=EPODOC&CC=WO&NR=2007009691A2
ParticipantIDs epo_espacenet_WO2007009691A2
PublicationCentury 2000
PublicationDate 20070125
PublicationDateYYYYMMDD 2007-01-25
PublicationDate_xml – month: 01
  year: 2007
  text: 20070125
  day: 25
PublicationDecade 2000
PublicationYear 2007
RelatedCompanies BUSCHMANN, HELMUT, H
LABORATORIOS DEL DR. ESTEVE, S.A
RelatedCompanies_xml – name: BUSCHMANN, HELMUT, H
– name: LABORATORIOS DEL DR. ESTEVE, S.A
Score 2.6613448
Snippet The present invention relates to an active substance combination comprising at least one substituted pyrazoline compound and at least one anti-addictive...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title ACTIVE SUBSTANCE COMBINATION
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070125&DB=EPODOC&locale=&CC=WO&NR=2007009691A2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1JS8NAFH6UKupNq-ISJaDkNtgsk-VQxEwSqtCm2LT2VjrJDAhSi434932ZNNpTb8MMvFnge9u8BeB-IbtBYSEAPS4pcWzPJNxzHSJkQLmQfteWKsp36PYnzsuMzlrw0eTCqDqhP6o4IiIqR7yXil-v_p1YkYqtXD_wd5z6fEyyXmQ01rGH_JYaUdiLR2mUMoMxtNuM4Wu9hup6YD4hw95DRdqrAsDiaVjlpay2hUpyDPsjpLcsT6Allh04ZE3vtQ4cDDZf3jjcoG99CloV8TGN9fEkHGdVUxmdpYPwuS5oewZ3SZyxPsFt5n-3mr-l22eyz6GN9r64AJ0WFFHHzdyvGoGIPECVhhe2JanwXddfXIK2i9LV7uVrOKrdkyaxqAbt8utb3KBcLfmteo5f2FV3Pw
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1JS8NAFH6UKtabVsUlakDJLdgsk-VQxGyk2iTFprW30klmQJBabMS_70vSaE-9DTPwZoHvbfMWgPsF79m5igA0KSeyrpmKTE1Dlxm3CWXc6mm8ivKNjXCiP8_IrAUfTS5MVSf0pyqOiIjKEO9Fxa9X_04sr4qtXD_Qd5z6fAzSvic11rGJ_JZIntP3R4mXuJLrot0mxa_1GqrrtvKEDHsPlWyrrLTvT50yL2W1LVSCI9gfIb1lcQwttuxCx216r3XhINp8eeNwg771CQhlxMfUF8cTZ5yWTWVEN4mcQV3Q9hTuAj91Qxm3mf_dav6WbJ9JO4M22vvsHESSE0QdVTKrbATCMhtVGpprKifMMgxrcQHCLkqXu5dvoROm0XA-HMQvV3BYuyoVWSUCtIuvb3aNMragN9XT_AKXR3ov
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ACTIVE+SUBSTANCE+COMBINATION&rft.inventor=BUSCHMANN%2C+HELMUT%2C+H&rft.date=2007-01-25&rft.externalDBID=A2&rft.externalDocID=WO2007009691A2